Bes Cemal
Department of Rheumatology, University of Health Sciences, Bakırköy Dr. Sadi Konuk Training and Research Hospital, İstanbul, Turkey.
Eur J Rheumatol. 2018 Jul 1;6(3):146-149. doi: 10.5152/eurjrheum.2019.19036. Print 2019 Jul.
Interstitial lung disease (ILD) is one of the extra-articular involvement forms of rheumatoid arthritis (RA), and it is associated with increased mortality. The presence of genetic susceptibility, smoking, rheumatoid factor positivity, and the presence of anticitrulline peptide antibodies are factors contributing to the development of ILD in patients with RA. Early diagnosis and treatment of ILD contribute to the reduction of morbidity and mortality. We herein evaluated the current literature for the diagnosis and treatment of RA-associated ILD.
间质性肺疾病（ILD）是类风湿关节炎（RA）关节外受累的形式之一，且与死亡率增加相关。遗传易感性、吸烟、类风湿因子阳性以及抗瓜氨酸肽抗体的存在是导致RA患者发生ILD的因素。ILD的早期诊断和治疗有助于降低发病率和死亡率。我们在此评估了关于RA相关ILD诊断和治疗的现有文献。
